We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Direct-to-consumer (DTC) marketers of genetic tests may need to reconsider the product claims they are making to avoid a clampdown on sales by the federal government.
The FCC is considering whether to expand available radio frequency (RF) for implanted and body-worn wireless devices, but manufacturers disagree on whether additional RF is needed.
BioProgress PLC, the speciality pharmaceutical and healthcare company, said it has obtained registration for its Hyposalix spray for dry mouth as a medical device, and plans to launch the product in the EU within six months.
A unique nerve-stimulation treatment for epilepsy developed at UCLA offers a potential new alternative for tens of thousands of individuals unable to control their seizures with medication and ineligible for surgery.
TriE Medical, Inc., a privately held medical device development company, has developed a shake/fire system for the testing of metered dose inhalers, to be used as a research tool, formulation device, and to collect regulatory submission data for verification and validation purposes.
"Illness, injury and disease" are the real "enemies" of the healthcare system, and not the cost of medical technology innovation, said one health expert in response to a July 20 article in the Pioneer Press on what some are calling a "medical arms race."